Fil LTD Coherus Bio Sciences, Inc. Transaction History

Fil LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$14.43 - $19.16 $4.68 Million - $6.22 Million	-324,589 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$11.67 - $22.53 $2.45 Million - $4.72 Million	-209,620 Reduced 39.24%	324,589 $5.27 Million
Q4 2019 Feb 07, 2020	BUY	$16.33 - $21.37 $1.04 Million - $1.36 Million	63,812 Added 13.57%	534,209 $9.62 Million
Q2 2019 Aug 13, 2019	BUY	$13.1 - $22.1 $6.16 Million - $10.4 Million	470,397 New	470,397 $10.4 Million

132

76.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $91.7M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

Stay updated on Fil LTD with notifications on news.